Minimal Residual Disease in NPM1-Mutated AML

被引：2
|
作者：
Burke, Michael J. [1 ,2 ]
机构：
[1] Med Coll Wisconsin, Dept Pediat, Div Hematol Oncol Blood & Marrow Transplantat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[2] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 05期
关键词：
ACUTE MYELOID-LEUKEMIA; CHILDRENS ONCOLOGY GROUP; RISK;
D O I：
10.1056/NEJMe1515525
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [21] Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML
    Othman, Jad
    Potter, Nicola
    Ivey, Adam
    Tazi, Yanis
    Papaemmanuil, Elli
    Jovanovic, Jelena
    Freeman, Sylvie D.
    Gilkes, Amanda
    Gale, Rosemary
    Rapoz-D'Silva, Tanya
    Runglall, Manohursingh
    Kleeman, Michelle
    Dhami, Pawan
    Thomas, Ian
    Johnson, Sean
    Canham, Joanna
    Cavenagh, Jamie
    Kottaridis, Panagiotis
    Arnold, Claire
    Ommen, Hans Beier
    Overgaard, Ulrik Malthe
    Dennis, Mike
    Burnett, Alan
    Wilhelm-Benartzi, Charlotte
    Huntly, Brian
    Russell, Nigel H.
    Dillon, Richard
    BLOOD, 2024, 144 (07) : 714 - 728
  • [22] Clonal Hematopoiesis Leading to AITL and NPM1-Mutated AML Reply
    Tiacci, Enrico
    Falini, Brunangelo
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2184 - 2185
  • [23] Clinical Relevance of Minimal Residual Disease Monitoring in NPM1 Mutated AML: A Study of the AML Study Group (AMLSG)
    Kapp-Schwoerer, Silke
    Corbacioglu, Andrea
    Weber, Daniela
    Gaidzik, Verena I.
    Paschka, Peter
    Kroenke, Jan
    Teleanu, Maria-Veronica
    Gohring, Gudrun
    Schlegelberger, Brigitte
    Fiedler, Walter
    Wulf, Gerald
    Salih, Helmut R.
    Lubbert, Michael
    Kindler, Thomas
    Gotze, Katharina S.
    Westermann, Joerg
    Mayer, Karin
    Wolf, Dominik
    Schroeder, Thomas
    Salwender, Hans Jurgen
    Machherndl-Spandl, Sigrid
    Bentz, Martin
    Ringhoffer, Mark
    Horst, Heinz A.
    Thol, Felicitas
    Heuser, Michael
    Krauter, Jurgen
    Schlenk, Richard F.
    Ganser, Arnold
    Dohner, Hartmut
    Dohner, Konstanze
    BLOOD, 2017, 130
  • [24] Clinical Relevance of Minimal Residual Disease Monitoring in NPM1 Mutated AML: A Study of the AML Study Group (AMLSG)
    Kapp-Schwoerer, Silke
    Corbacioglu, Andrea
    Gaidzik, Verena I.
    Paschka, Peter
    Weber, Daniela
    Kroenke, Jan
    Teleanu, Maria-Veronica
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Luebbert, Michael
    Kindler, Thomas
    Wattad, Mohammad Amen
    Kuendgen, Andrea
    Nachbaur, David
    Fielder, Walter
    Salih, Helmut Rainer
    Horst, Heinz A.
    Mayer, Karin Tina
    Goetze, Katharina S.
    Bentz, Martin
    Schleicher, Jan
    Thol, Felicitas
    Heuser, Michael
    Krauter, Juergen
    Ganser, Arnold
    Schlenk, Richard F.
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2015, 126 (23)
  • [25] CLINICAL RELEVANCE OF MINIMAL RESIDUAL DISEASE MONITORING IN NPM1 MUTATED AML: A STUDY OF THE AML STUDY GROUP (AMLSG)
    Kapp-Schwoerer, S.
    Kroenke, J.
    Corbacioglu, A.
    Gaidzik, V.
    Paschka, P.
    Eiwen, K.
    Spaeth, D.
    Goehring, G.
    Schlegelberger, B.
    Luebbert, M.
    Kindler, T.
    Wattad, M.
    Germing, U.
    Nachbaur, D.
    Fiedler, W.
    Heuser, M.
    Krauter, J.
    Ganser, A.
    Schlenk, R.
    Doehner, H.
    Doehner, K.
    HAEMATOLOGICA, 2013, 98 : 484 - 485
  • [26] Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field
    Brunangelo Falini
    Sofia Sciabolacci
    Lorenza Falini
    Lorenzo Brunetti
    Maria Paola Martelli
    Leukemia, 2021, 35 : 3113 - 3126
  • [27] Clinical Outcomes in De Novo Versus Secondary NPM1-Mutated AML
    Smith, Elliot C.
    Atenafu, Eshetu G.
    Bankar, Aniket
    Chan, Steven M.
    Davidson, Marta B.
    Gupta, Vikas
    Minden, Mark D.
    Richard-Carpentier, Guillaume
    Schimmer, Aaron D.
    Schuh, Andre C.
    Sibai, Hassan
    Yee, Karen
    Maze, Dawn
    BLOOD, 2022, 140 : 8952 - 8953
  • [28] Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML
    Matthieu Duchmann
    Romane Joudinaud
    Augustin Boudry
    Justine Pasanisi
    Giuseppe Di Feo
    Rathana Kim
    Maxime Bucci
    Clémentine Chauvel
    Laureen Chat
    Lise Larcher
    Kim Pacchiardi
    Stéphanie Mathis
    Emmanuel Raffoux
    Lionel Adès
    Céline Berthon
    Emmanuelle Clappier
    Christophe Roumier
    Alexandre Puissant
    Claude Preudhomme
    Nicolas Duployez
    Raphaël Itzykson
    Blood Cancer Journal, 12
  • [29] Current status and future perspectives in targeted therapy of NPM1-mutated AML
    Roberta Ranieri
    Giulia Pianigiani
    Sofia Sciabolacci
    Vincenzo Maria Perriello
    Andrea Marra
    Valeria Cardinali
    Sara Pierangeli
    Francesca Milano
    Ilaria Gionfriddo
    Lorenzo Brunetti
    Maria Paola Martelli
    Brunangelo Falini
    Leukemia, 2022, 36 : 2351 - 2367
  • [30] Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML
    Duchmann, Matthieu
    Joudinaud, Romane
    Boudry, Augustin
    Pasanisi, Justine
    Di Feo, Giuseppe
    Kim, Rathana
    Bucci, Maxime
    Chauvel, Clementine
    Chat, Laureen
    Larcher, Lise
    Pacchiardi, Kim
    Mathis, Stephanie
    Raffoux, Emmanuel
    Ades, Lionel
    Berthon, Celine
    Clappier, Emmanuelle
    Roumier, Christophe
    Puissant, Alexandre
    Preudhomme, Claude
    Duployez, Nicolas
    Itzykson, Raphael
    BLOOD CANCER JOURNAL, 2022, 12 (09)
12345